Day December 16, 2021

The TRIPS Waiver: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19

This research event focused upon the geopolitical debate over access to essential medicines during the coronavirus public health crisis. I brought together researchers, experts and scholars working in the field of access to essential medicines — ranging through the disciplines of intellectual property, public health law, human rights, international law, and trade law.